ENVB Stock Summary and Trading Ideas (Enveric Biosciences | NASDAQ:ENVB)

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

Enveric Biosciences trades on the NASDAQ stock market under the symbol ENVB.

As of March 5, 2025, ENVB stock price declined to $2.10 with 249,645 million shares trading.

ENVB has a beta of 0.08, meaning it tends to be less sensitive to market movements. ENVB has a correlation of 0.00 to the broad based SPY ETF.

ENVB has a market cap of $4.04 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ENVB traded as high as $300.00 and as low as $1.13.

The top ETF exchange traded funds that ENVB belongs to (by Net Assets): PSIL, VXF.

ENVB has underperformed the market in the last year with a return of -91.0%, while the SPY ETF gained +15.2%. In the last 3 month period, ENVB fell short of the market, returning -56.7%, while SPY returned -3.7%. However, in the most recent 2 weeks ENVB has outperformed the stock market by returning +32.9%, while SPY returned -4.6%.

ENVB support price is $1.90 and resistance is $2.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENVB shares will trade within this expected range on the day.